Documents

  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge

Folder 2nd Human Challenge

  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Abha Saxena Ethical considerations for Human Challenge Studies The WHO perspective

pdf Abha Saxena Ethical considerations for Human Challenge Studies The WHO perspective

By 806 downloads

Download (pdf, 2.44 MB)

Abha Saxena_Ethical considerations for Human Challenge Studies-The WHO perspective.pdf

Abha Saxena Ethical considerations for Human Challenge Studies The WHO perspective
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Alan Fauconnier The status of challenge material within the EU regulatory framework

pdf Alan Fauconnier The status of challenge material within the EU regulatory framework

By 745 downloads

Download (pdf, 798 KB)

Alan Fauconnier_The status of challenge material within the EU regulatory framework.pdf

Alan Fauconnier The status of challenge material within the EU regulatory framework
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Alan Fix Challenge assessment of a novel rotavirus vaccine

pdf Alan Fix Challenge assessment of a novel rotavirus vaccine

By 771 downloads

Download (pdf, 992 KB)

Alan Fix_Challenge assessment of a novel rotavirus vaccine.pdf

Alan Fix Challenge assessment of a novel rotavirus vaccine
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Anna Durbin Dengue infection model

pdf Anna Durbin Dengue infection model

By 718 downloads

Download (pdf, 1.38 MB)

Anna Durbin_Dengue infection model.pdf

Anna Durbin Dengue infection model
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Anna Durbin Role of a ZIKV CHIM in vaccine evaluation

pdf Anna Durbin Role of a ZIKV CHIM in vaccine evaluation

By 788 downloads

Download (pdf, 1.42 MB)

Anna Durbin_Role of a ZIKV CHIM in vaccine evaluation.pdf

Anna Durbin Role of a ZIKV CHIM in vaccine evaluation
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Beth D Kirkpatrick CHIM Opportunities in human immunology

pdf Beth D Kirkpatrick CHIM Opportunities in human immunology

By 789 downloads

Download (pdf, 2.38 MB)

Beth D. Kirkpatrick_CHIM-Opportunities in human immunology.pdf

Beth D Kirkpatrick CHIM Opportunities in human immunology
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Bridget Wills A dengue Controlled Human Infection Model in Vietnam

pdf Bridget Wills A dengue Controlled Human Infection Model in Vietnam

By 836 downloads

Download (pdf, 1.96 MB)

Bridget Wills_A dengue Controlled Human Infection Model in Vietnam .pdf

Bridget Wills A dengue Controlled Human Infection Model in Vietnam
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Bruno Speder Regulatory considerations regarding the development of the SGS A Belgium 4217 2015 H3N2 challenge agent

pdf Bruno Speder Regulatory considerations regarding the development of the SGS A Belgium 4217 2015 H3N2 challenge agent

By 790 downloads

Download (pdf, 945 KB)

Bruno Speder_Regulatory considerations regarding the development of the SGS A-Belgium-4217-2015 H3N2 challenge agent.pdf

Bruno Speder Regulatory considerations regarding the development of the SGS A Belgium 4217 2015 H3N2 challenge agent
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Caroline Lyon A CHIM site's experience with an FDA inspection

Default Caroline Lyon A CHIM site's experience with an FDA inspection

By 723 downloads

Download (pdf, 472 KB)

Caroline Lyon_A CHIM site's experience with an FDA inspection.pdf

  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Chad Porter Development, use and refinement of enterotoxigenic Escherichia coli (ETEC) controlled human infection

Default Chad Porter Development, use and refinement of enterotoxigenic Escherichia coli (ETEC) controlled human infection

By 745 downloads

Download (pdf, 1.43 MB)

Chad Porter_Development, use and refinement of enterotoxigenic Escherichia coli (ETEC) controlled human infection.pdf

  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Christopher Chiu Dissecting immunity to RSV using Human Challenge Trials

Default Christopher Chiu Dissecting immunity to RSV using Human Challenge Trials

By 758 downloads

Download (pdf, 2.02 MB)

Christopher Chiu_Dissecting immunity to RSV using Human Challenge Trials.pdf

  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. David Tribble Enteric pathogen safety considerations in Human Challenge Trials

Default David Tribble Enteric pathogen safety considerations in Human Challenge Trials

By 708 downloads

Download (pdf, 345 KB)

David Tribble_Enteric pathogen safety considerations in Human Challenge Trials.pdf

  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. DOMINI~1

Default DOMINI~1

By 783 downloads

Download (pdf, 6.64 MB)

DOMINI~1.PDF

  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Helen McShane Developing a human mycobacterial challenge model

Default Helen McShane Developing a human mycobacterial challenge model

By 734 downloads

Download (pdf, 1.53 MB)

Helen McShane_Developing a human mycobacterial challenge model.pdf

  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. IABS 2nd Human Challenge Trials in Vaccine Development Final Agenda

pdf IABS 2nd Human Challenge Trials in Vaccine Development Final Agenda

By 739 downloads

Download (pdf, 365 KB)

IABS_2nd Human Challenge Trials in Vaccine Development_Final Agenda.pdf

IABS 2nd Human Challenge Trials in Vaccine Development Final Agenda
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Ivana Knezevic WHO Guidelines

pdf Ivana Knezevic WHO Guidelines

By 757 downloads

Download (pdf, 1.49 MB)

Ivana Knezevic_WHO Guidelines.pdf

Ivana Knezevic WHO Guidelines
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. John Treanor Pediatric influenza and rotavirus challenge models

pdf John Treanor Pediatric influenza and rotavirus challenge models

By 751 downloads

Download (pdf, 667 KB)

John Treanor_Pediatric influenza and rotavirus challenge models.pdf

John Treanor Pediatric influenza and rotavirus challenge models
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Jona Walk Managing safety in Controlled Human Malaria Infections

pdf Jona Walk Managing safety in Controlled Human Malaria Infections

By 693 downloads

Download (pdf, 792 KB)

Jona Walk_Managing safety in Controlled Human Malaria Infections.pdf

Jona Walk Managing safety in Controlled Human Malaria Infections
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Marc Gurwith Cholera Human Challenge as pivotal efficacy study

pdf Marc Gurwith Cholera Human Challenge as pivotal efficacy study

By 727 downloads

Download (pdf, 1.12 MB)

Marc Gurwith_Cholera Human Challenge as pivotal efficacy study.pdf

Marc Gurwith Cholera Human Challenge as pivotal efficacy study
  1. Conferences and Webinars
    2. »
  2. 2017
    3. »
  3. 2nd Human Challenge
    4. »
  4. Mark Riddle Bioconjugate vaccine preventing shigellosis bridge from HCT to field studies

pdf Mark Riddle Bioconjugate vaccine preventing shigellosis bridge from HCT to field studies

By 693 downloads

Download (pdf, 1.70 MB)

Mark Riddle_Bioconjugate vaccine preventing shigellosis-bridge from HCT to field studies.pdf

Mark Riddle Bioconjugate vaccine preventing shigellosis bridge from HCT to field studies
 

 

IABS
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.